Wordt geladen...
Tau Immunotherapies for Alzheimer’s Disease and Related Tauopathies: Progress and Potential Pitfalls.
Tau immunotherapies have now advanced from proof-of-concept studies to Phase 2 clinical trials. This review briefly outlines developments in the field and discusses how these therapies may work, which involves multiple variables that are connected in complex ways. These various factors are likely to...
Bewaard in:
| Gepubliceerd in: | J Alzheimers Dis |
|---|---|
| Hoofdauteur: | |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6171771/ https://ncbi.nlm.nih.gov/pubmed/29865056 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JAD-179937 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|